IMHO this speaks so loudly that the CEO and the Harrow CFO are not fit for this job....
The company set up by the previous CEO is now being destroyed by delay and dilution.....
As you can tell you know what i think...and by the way don't get too sucked in by the carrot of a nasdaq listing.. IMHO it will be "imminent and costly" can someone show me where this has been successful from an aussie biotech in the past...
IMHO a lot of hot air from the CFO & CEO to distract from their destruction
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable